Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A high neutrophil-to-lymphocyte ratio may predict poor response to hair loss treatment.

Trichoscopy helps correctly diagnose alopecia areata, not syphilitic alopecia, in patients with recent syphilis.

Psoriasis patients are more likely to develop alopecia areata due to complex autoimmune interactions.

BMD-1141 effectively regrows hair in alopecia areata with less frequent dosing than current treatments.

Tofacitinib can help regrow hair in about 50% of people with moderate-severe alopecia areata.

Frontal fibrosing alopecia in men is often misdiagnosed and needs better diagnostic criteria and treatment strategies.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Alopecia areata patients have higher IgE and IL-13 levels, suggesting immune involvement.

Japanese patients and physicians often disagree on the severity of Alopecia Areata and treatment satisfaction, needing better communication and treatments.

Alopecia areata causes sudden hair loss, has genetic links, and can be managed but not cured.

Melanocytes may trigger the immune response in alopecia areata, affecting hair regrowth.

Ayurvedic treatment successfully regrew hair in a 7-year-old girl with alopecia areata.

Dupilumab may help hair regrowth in some patients with severe atopic dermatitis, but results vary.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.

There's no link between low iron levels and the hair loss condition, alopecia areata.

The combination of PRP and triamcinolone injections improved hair growth in a man with alopecia areata.

Alopecia areata causes patchy hair loss and involves immune system disruptions.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

Certain factors like patchy hair loss at the back of the head, being female, and younger age at diagnosis can lead to a worse outcome for alopecia areata.

Trichoscopy and trichogram are useful for diagnosing hair and scalp conditions.

Both atopy and eosinophilia are linked to more severe hair loss in people with alopecia areata.

The study found that severe alopecia areata affects any age, treatments often give temporary results, and some factors predict worse outcomes.

Alopecia areata is an autoimmune disease affecting hair follicles and may harm heart health.

The document concludes that current treatments for androgenic alopecia are not fully effective, but new therapies like botulinum toxin and PRP show promise, and future gene therapy could be beneficial.

The study concluded that patients with total hair loss and recurring hair loss had an earlier onset, longer-lasting condition, and a greater negative impact on their quality of life, with allergic conditions linked to more severe hair loss.

Alopecia areata has different forms and can significantly affect quality of life, especially in more severe cases.

Mast cells play a significant role in hair loss conditions like male pattern hair loss and alopecia areata.

Hair and nail conditions can stabilize or improve over time, and new treatments show promise.